Press

Sitero tagline Logo

Sitero Signs Agreement to Acquire Axiom Real-Time Metrics, Expanding Global Footprint and Strengthening Technology-Enabled Clinical Services

MIAMI, Fla., July 7, 2025 /PRNewswire/ — Sitero, a leading provider of clinical and regulatory services, today announced that it has signed a definitive agreement to acquire the assets and business of Axiom Real-Time Metrics Inc. from its proposed court-appointed receiver and manager, KSV Restructuring Inc., Axiom is recognized for its innovation in eClinical solutions […]

Sitero Signs Agreement to Acquire Axiom Real-Time Metrics, Expanding Global Footprint and Strengthening Technology-Enabled Clinical Services Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – ELV

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – ELV Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SRPT

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address,

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SRPT Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – RCKT

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number,

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – RCKT Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Krispy Kreme, Inc. of Class Action Lawsuit and Upcoming Deadlines – DNUT

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address,

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Krispy Kreme, Inc. of Class Action Lawsuit and Upcoming Deadlines – DNUT Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines – RBGLY

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc (“Reckitt” or the “Company”) (OTCMKTS: RBGLY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines – RBGLY Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Companies, Inc. of Class Action Lawsuit and Upcoming Deadlines – RKT

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit is pending against Rocket Companies, Inc. (“Rocket Companies” or the “Company”) (NYSE: RKT). Investors in Rocket Companies securities are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Companies, Inc. of Class Action Lawsuit and Upcoming Deadlines – RKT Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass Diversified Holdings of Class Action Lawsuit and Upcoming Deadlines – CODI

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Compass Diversified Holdings (“CODI” or the “Company”) (NYSE: CODI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address,

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass Diversified Holdings of Class Action Lawsuit and Upcoming Deadlines – CODI Read Post »

Press
Scroll to Top